AAAAAA

   
Results: 1-10 |
Results: 10
Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to diseaseseverity and autoimmune pathogenesis
Authors: Caforio, ALP Goldman, JH Baig, MK Mahon, NJ Haven, AJ Souberbielle, BE Holt, DW Dalgleish, AG McKenna, WJ
Citation: Alp. Caforio et al., Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to diseaseseverity and autoimmune pathogenesis, EUR J HE FA, 3(2), 2001, pp. 155-163
Monoclonal gammopathy in heart transplantation: Risk factor analysis and relevance of immunosuppressive load
Authors: Caforio, ALP Gambino, A Fortina, AB Piaserico, S Scarpa, E Feltrin, G Tona, F Pompei, E Tonin, E Amadori, G Thiene, G Dalla Volta, S Peserico, A Casarotto, D
Citation: Alp. Caforio et al., Monoclonal gammopathy in heart transplantation: Risk factor analysis and relevance of immunosuppressive load, TRANSPLAN P, 33(1-2), 2001, pp. 1583-1584
High rejection score in the first year and risk of skin cancer in heart transplantation
Authors: Caforio, ALP Fortina, AB Gambino, A Piaserico, S Feltrin, G Tona, F Pompei, E Testolin, L Gai, F Angelini, A Casarotto, D Peserico, A
Citation: Alp. Caforio et al., High rejection score in the first year and risk of skin cancer in heart transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1608-1609
Heart donor management and expansion of current donor selection criteria
Authors: Livi, U Caforio, ALP
Citation: U. Livi et Alp. Caforio, Heart donor management and expansion of current donor selection criteria, J HEART LUN, 19(8), 2000, pp. S43-S48
Skin cancer in heart transplant recipients: Frequency and risk factor analysis
Authors: Fortina, AB Caforio, ALP Piaserico, S Alaibac, M Tona, F Feltrin, G Livi, U Peserico, A
Citation: Ab. Fortina et al., Skin cancer in heart transplant recipients: Frequency and risk factor analysis, J HEART LUN, 19(3), 2000, pp. 249-255
Sulfinpyrazone reduces cyclosporine levels. A new drug interaction in heart transplant recipients
Authors: Caforio, ALP Gambino, A Tona, F Feltrin, G Marchini, F Pompei, E Testolin, L Angelini, A Dalla Volta, S Casarotto, D
Citation: Alp. Caforio et al., Sulfinpyrazone reduces cyclosporine levels. A new drug interaction in heart transplant recipients, J HEART LUN, 19(12), 2000, pp. 1205-1208
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy
Authors: Caforio, ALP Fortina, AB Piaserico, S Alaibac, M Tona, F Feltrin, G Pompei, E Testolin, L Gambino, A Dalla Volta, S Thiene, G Casarotto, D Peserico, A
Citation: Alp. Caforio et al., Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy, CIRCULATION, 102(19), 2000, pp. 222-227
Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
Authors: Mestroni, L Rocco, C Gregori, D Sinagra, G Di Lenarda, A Miocic, S Vatta, M Pinamonti, B Muntoni, F Caforio, ALP McKenna, WJ Falaschi, A Giacca, M Camerini, F
Citation: L. Mestroni et al., Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity, J AM COL C, 34(1), 1999, pp. 181-190
The pathophysiology of advanced heart failure (Reprinted from Am Heart J, vol 135, pg S216-S230, 1998)
Authors: Baig, MK Mahon, N McKenna, WJ Caforio, ALP Bonow, RO Francis, GS Gheorghiade, M
Citation: Mk. Baig et al., The pathophysiology of advanced heart failure (Reprinted from Am Heart J, vol 135, pg S216-S230, 1998), HEART LUNG, 28(2), 1999, pp. 87-101
Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy
Authors: de Leeuw, N Melchers, WJG Ruiter, DJ Caforio, ALP Balk, AHMM de Jonge, N Galama, JMD
Citation: N. De Leeuw et al., Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy, J CLIN PATH, 52(10), 1999, pp. 739-743
Risultati: 1-10 |